| Similar Articles |
|---|
 |
Popular Mechanics
February 5, 2010
Adam Hadhazy |
Anti-Vaccination Groups Dealt Blow as Lancet Study is Retracted In what will likely be a big blow to the anti-vaccination movement, The Lancet medical journal has retracted the 1998 study by Dr. Andrew Wakefield that originally sparked the uproar over whether vaccines are linked to autism.   |
American Family Physician
December 1, 2002
Sanford R. Kimmel |
Vaccine Adverse Events: Separating Myth from Reality Vaccines have turned many childhood diseases into distant memories in industrialized countries. However, questions have been raised about the safety of some vaccines because of rare but serious adverse effects that have been attributed to them. |
Reason
July 2008
Ronald Bailey |
Needling Vaccines A federal vaccine court rules that the preponderance of the evidence suggested that a 9-year-old girl's autism was caused by her childhood vaccinations. |
Salon.com
August 2, 2000
Lesli Mitchell |
Secrets and lies Is the astonishing rise in autism a medical mystery or a pharmaceutical shame? |
Salon.com
April 13, 2000
Arthur Allen |
Inoculated into oblivion When families hit the Capitol last week, they demanded answers about the source of their children's autism. |
Salon.com
August 2, 2000
Arthur Allen |
A recipe for disaster While nobody knows the origin of autism, many researchers worry that linking it to childhood vaccines could be a very dangerous theory. |
Nurse Practitioner
April 2010
McCravy et al. |
Speak the language of autism Autism affects 1 in 110 children and 1 in 70 boys in the United States. |
Salon.com
October 26, 1999
Jon Bowen |
Disease parties Some parents in Britain are deliberately exposing their children to kids with contagious illnesses. |
Health
October 2007
Sarah Clachar |
Read this BEFORE you get a flu shot The flu vaccine may not be as good -- or as safe -- as you think. |
American Family Physician
July 15, 2003
Sur et al. |
Vaccinations in Pregnancy Routine vaccines that generally are safe to administer during pregnancy include diphtheria, tetanus, influenza, and hepatitis B. Other vaccines, such as meningococcal and rabies, may be considered. |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
Health
May 2008
Jessica Snyder Sachs |
Seven Vaccines You Need Right Now Why those childhood shots (whooping cough, mumps, and more) may have worn off - and what to do. |
BusinessWeek
October 22, 2007
Catherine Arnst |
Roll Up Your Sleeve, Gramps A graying population may create a huge market for vaccines that buttress aging immune systems. |
American Family Physician
November 1, 2002
Prater & Zylstra |
Autism: A Medical Primer Autistic disorder, a pervasive developmental disorder resulting in social, language, or sensorimotor deficits, occurs in approximately seven of 10,000 persons. Early detection and intervention significantly improve outcome. |
American Family Physician
July 1, 2004
Lo Re & Gluckman |
Travel Immunizations The approach to vaccine recommendations should be based on a thorough assessment of the risks for travel-related diseases, the time available before trip departure, and current knowledge of the epidemiology of vaccine-preventable diseases. |
Managed Care
October 2000
Kevin A. Wilson |
Public Policy Largely Ignores Adult Immunization Needs Although four fifths of the nation's children are fully immunized, tens of thousands of adults die each year from diseases preventable by vaccination... |
Pharmaceutical Executive
December 1, 2005
Anthony Tao |
The Avian Few: Is it Too Late for Pharma to Re-enter the Vaccine Fray? Small profit margins and high litigation risks drove most companies out of the vaccine business decades ago. As a possible pandemic looms, pharma re-enters the fray. Is it too late? |
Popular Mechanics
August 2008
Glenn Harlan Reynolds |
As Diseases Make Comeback, Why Aren't All Kids Vaccinated? The measles, whooping cough and even polio have returned. Why? Because of a new breed of vaccine deniers who are ignoring campaigns for awareness, and ultimately might live shorter lives. |
Wired
September 2001
Sara Solovitch |
The Citizen Scientists United by the Net and emboldened by their numbers, parents of desperately ill children are funneling millions into research, building vast genetic databases, and rewriting the rules of the medical industry.... |
Bio-IT World
June 15, 2003
Malorye Branca |
A View to a Kill Genomics, bioinformatics, and novel laboratory techniques are converging to boost vaccine research against a new wave of emerging diseases, natural and man-made. Now, will in silico modeling ramp up sufficiently to further speed vaccine discovery? |
Salon.com
March 8, 2001
Amy Standen |
Ready for some lockjaw? There's no profit in the tetanus vaccine business, so a rare and hideous disease may soon strike more Americans... |
Chemistry World
January 19, 2015
Maria Burke |
Roadmap to fast track Ebola vaccine development A global group of experts has developed a 'roadmap' to help the health community fast track an Ebola vaccine. |
Pharmaceutical Executive
February 1, 2009
Joanna Breitstein |
Vaccines for All The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most. |
Popular Mechanics
September 2006
Ben Harder |
Seeking Immunity Pathogens like West Nile virus show no respect for borders. But a new class of vaccines may soon keep them in check. |
Wired
September 2002
Amanda Griscom |
Take These Genes and Call Me in the Morning Gene vaccines may be relatively new, but they're the logical outgrowth of two familiar strands of medical science. |
Pharmaceutical Executive
May 1, 2006
Pasternak et al. |
Vaccines: Market on the Rebound The vaccine business was safely inoculated against higher profits. But innovative therapies and looser government controls may spark an outbreak. Are pharmaceuticals ready for this opportunity? |
American Family Physician
May 15, 2001
Richard Kent Zimmerman |
Pneumococcal Conjugate Vaccine for Young Children Pneumococcal conjugate vaccine, approved in 2000 for use in the United States, was designed to cover the seven serotypes that account for about 80 percent of invasive infections in children younger than six years... |
Chemistry World
September 26, 2007
Victoria Gill |
HIV Vaccines 'Will Not Work' Just days after US drug firm Merck revealed its leading HIV vaccine candidate had flopped in clinical trials, a leading immunologist has predicted that many other vaccines in the pipeline will also fail because their design is similarly flawed. |
American Family Physician
July 1, 2000
Monica Preboth |
Practice Guidelines ACIP Issues Recommendations for the 2000-2001 Influenza Season |
American Family Physician
July 1, 2000
Monica Preboth |
Clinical Briefs ISMP Warning on Heparin/Hespan Mix-ups... Increase in Vaccination Coverage Levels... Therapies for the Prevention of Breast Cancer... Online Service to Provide Hospital Statistics... Office Spirometry for the Detection of COPD... AAFP Annual Scientific Assembly... etc. |
Chemistry World
August 5, 2015
Emma Stoye |
Vaccine raises hopes of an end to Ebola A Phase III trial for a candidate Ebola vaccine has shown extremely encouraging results in Guinea, demonstrating complete protection for all those who were vaccinated. |
American Family Physician
September 1, 2003
Maurer et al. |
Smallpox Vaccine: Contraindications, Administration, and Adverse Reactions Public health departments and the U.S. military have begun the process of vaccinating soldiers and civilian first-responders. Smallpox vaccination carries some serious risks. |
The Motley Fool
December 30, 2008
Brian Orelli |
A Shot in the Arm for Novartis' Pipeline The company picks up the rights to a vaccine that fights a virus. |
Pharmaceutical Executive
May 1, 2006
Joanna Breitstein |
Cervical Cancer: Endagered Species Preventive care is more efficient than treating disease after the fact. Now this paradigm takes hold in cancer with new HPV vaccines. Now that the science is in order, Merck and GSK face several important challenges in conditioning the market. |
Scientific American
April 10, 2006
Christine Soares |
Turning Yellow Yellow fever shot confers long-lasting immunity, a trait that medical researchers hope to transfer to other kinds of vaccines. |
Managed Care
December 2006
Thomas Morrow |
Herpes Zoster Vaccine Brings Relief for the Elderly Vaccines for chickenpox and herpes, the two variations of the varicella-zoster virus, are now available for children and the elderly, respectively. |
Scientific American
November 2008
Jessica Wapner |
Cancer Vaccine: Looking Beyond Tumor Size Proponents see hope in changing cancer vaccines' bad reputation |
Pharmaceutical Executive
July 10, 2014
Fitzpatrick & Mohan |
Vaccines: Fire in the Cold Chain It's only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance. |
BusinessWeek
April 30, 2007
Catherine Arnst |
Teaching The Body To Fix Itself Cancer vaccines still in trial stages may be able to prolong life with few side effects, but the FDA has yet to be convinced. |
HBS Working Knowledge
March 1, 2004
Martha Lagace |
Injecting New Life into the Vaccine Industry Vaccines for preventable diseases save millions of lives every year, yet as an industry, the vaccine business suffers a host of ailments, the CEO of Merck & Co. contends. |
BusinessWeek
January 14, 2010
Ellen Gibson |
The Hunt for an Autism Drug Armed with fresh medical insights, drug companies are redoubling their efforts to address the disease's complex causes. |
BusinessWeek
July 25, 2005
Catherine Arnst |
O.K., Roll Up Your Sleeve New vaccines are arriving but the economics are still a challenge. |
Scientific American
February 2006 |
To Banish a Cancer Two vaccines that are nearing approval by the Food and Drug Administration in the U.S. have demonstrated in clinical trials that they can prevent infection from the two types of the human papillomavirus (HPV) that account for up to 70 percent of cervical cancers. |
Chemistry World
March 17, 2011
Hepeng Jia |
International recognition helps Chinese vaccine industry Vaccines made in China will now be supplied through United Nations agencies to developing countries, after recognition from the World Health Organisation that China's State Food and Drug Administration has complied with international standards for vaccine regulation. |
BusinessWeek
November 28, 2005
Kerry Capell |
High-Velocity Vaccines PowderMed says its DNA technology would let it react quickly to a flu pandemic. A DNA flu vaccine would have huge advantages over traditional ones. But first, the company must prove in upcoming large-scale clinical trials that its vaccine can protect people from flu generally. |
Managed Care
January 2008
Martin Sipkoff |
Should Pharmacists Be Allowed To Vaccinate Their Patients? Although federal health agencies support the idea of having pharmacists administer vaccines to their patients, the roadblock continues to be a question of payment. |
American Family Physician
May 15, 2001 |
Pneumococcal Conjugate Vaccine: What a Parent Needs to Know Why should my child get this vaccine?... What exactly is the pneumococcal vaccine?... Are there some children who should not get pneumococcal conjugate vaccine or who should wait until they are older?... |
BusinessWeek
November 29, 2004
Kerry Capell |
"A Vaccine Every Woman Should Take" Two drug companies are closing in on shots against HPV, the leading cause of cervical cancer. Despite the obvious benefits, the vaccines may not be an easy sell: There are social and moral hurdles to overcome. |
American Family Physician
November 1, 2002 |
What You Should Know About Autism What is autism?... How can I tell if my child is autistic?... How is autism treated?... Where can I get more information?... |
The Motley Fool
September 25, 2007
Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
